Ngm Biopharmaceuticals Inc SC 13D and SC 13D/A reports

Location
333 Oyster Point Boulevard, South San Francisco, CA
State of incorporation
DE
Fiscal year end
December 31
Data updated at
7/19/2024, 08:56 AM
Form type Sec Links Description Filing date Reporting date
SC 13D/A Report AMENDMENT NO. 8 Apr 5, 2024
SC 13D/A Report AMENDMENT NO. 7 Feb 26, 2024
SC 13D/A Report AMENDMENT NO. 6 Dec 29, 2023
SC 13D/A Report SC 13D/A Jun 10, 2022
SC 13D/A Report SC 13D/A Feb 3, 2022
SC 13D/A Report SC 13D/A Apr 2, 2020
SC 13D/A Report SC 13D/A Oct 18, 2019
SC 13D/A Report SC 13D/A May 17, 2019
SC 13D Report SC 13D Apr 12, 2019